Antifungals Flashcards
what layer do superficial, subcutaneous, and systemic mycoses affect
superficial: outermost layers of skin, nails, hair, mucous membranes
subcutaneous: dermis, subcutaneous tissue, and adjacent bone
systemic - internal organs
antifungals that affect cell membrane permeability
polyenes - amphotericin B and nyostatin
azoles: ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, clotrimazole, miconazole
allylamines - terbinafine
antifungal that blocks nucleic acid synthesis
flucytosine
antifungal that disrupts microtubule function
Griseofulvin
antifungal that disrupts the fungal cell wall
echinocandins: caspofungin
what are the antifungal systemic drugs for subcutaneous and systemic mycoses
Flucytosine
Azoles: PFVIK – posaconazole, fluconazole, voriconazole, itraconazole, ketoconazole
Polyenes: amphotericin B
Echinocandins: Caspofungin
what are the systemic antifungals for superficial mycoses
GAA
Griseofulvin
Allylamines: Terbinafine
Azoles: FIK – fluconazole, itraconazole, ketoconazole
what are the topical antifungals for superficial mycoses
Polyenes: amphotericin B and Nystatin
Allylamines: Terbinafine
Azoles: CMK – clotrimazole, miconazole, ketoconazole
mechanism of amphoTEARricin B
bind to ergosterol and TEARS a hole/form pores in cell membrane –> leakage of intracellular ions and macromolecules –> cell death
drug of use for deep fungal infections during pregnancy
amphotericin B
what phase is amphotericin B used in and why?
it is usually used in the induction phase to rapidly reduce fungal burden then replaced with an azole for chronic use
conditions amphotericin B commonly used in
mucormycosis, cryptococcal meningitis, histoplasmosis, blastomycosis, coccidiodomycosis, extracutaneous sporotrichosis, fusariosis, and other systemic fungal infections
what is usually given before treatment of amphotericin B
saline solution to keep the electrolytes balanced
common adverse effects of amphotericin B
RENAL TOXICITY due to amphotericin B binding to cholesterol in mammalian cell membrane and forming pores
magnesium and potassium wasting hence why saline is given
what steps have been taken to reduce nephrotoxicity with amphotericin B
formulation of lipid amphotericin B such as
Liposomal Amphotericin B (L-AMB)
Amphotericin B Lipid Complex (ABLC)
Amphotericin B Colloid Complex (ABCC)
they all decrease drug exposure to proximal tubule of the nephron
mechanism of flucystosine
converted to 5-fluorouracil –> 5 fluorodeoxyuridine –> inhibits thymidylate sythetase –> blocks synthesis of
fluorouridine triphosphate also formed –> blocks protein synthesis